Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 21/12/19941 min de leitura
Animal Drugs, Feeds, and Related Products; Albendazole Suspension
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by SmithKline Beecham Animal Health Products. The NADA provides for use of albendazole suspension (Valbazen ) as an anthelmintic in sheep. The regulations are also amended to establish a tolerance for albendazole residue in sheep liver.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →